Engineering Nanoparticles and Bioscaffolds for Targeted microRNA Delivery in Cardiovascular Regeneration-A...

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cardiovascular Research

Background:

• Myocardial infarction (MI) causes significant cardiomyocyte loss and limited heart regeneration, leading to heart failure and high mortality.
• Current treatments like heart transplantation are limited by donor availability and immune rejection.
• MicroRNAs (miRNAs) regulate post-ischemic myocardial healing, with some promoting angiogenesis, but face delivery challenges.

Purpose of the Study:

• To review the role of miRNAs in post-MI cardiovascular remodeling.
• To identify challenges in miRNA-based therapy delivery.
• To explore nanoparticles and engineered bioscaffolds as solutions for cardiac regeneration.

Main Methods:

• Review of existing literature on miRNA function in cardiac repair.
• Analysis of nanoparticle-based delivery systems for miRNAs.
• Evaluation of electrospun nanofibrous scaffolds for cardiac tissue engineering.

Main Results:

• Specific miRNAs (e.g., miR-92a, miR-126, miR-145) show potential in promoting angiogenesis post-MI.
• Nanoparticles offer a promising approach to overcome extracellular and intracellular miRNA delivery barriers.
• Engineered bioscaffolds, particularly nanofibrous ones, can provide a supportive microenvironment for cardiac regeneration.

Conclusions:

• Nanoparticles and advanced bioscaffolds are crucial for effective miRNA-based cardiac regeneration therapies.
• Overcoming miRNA delivery challenges is key to developing novel treatments for myocardial infarction.
• Future research should focus on optimizing nanofibrous scaffolds for enhanced cardiac repair and functional recovery.